Finally, it should be noted that down-regulation of miR-34a by XRN1 might contribute to PCa progression independent of AR, since miR-34a can act as a tumor suppressor through directly inhibiting CD44 in tumorigenic and metastatic PCa stem cells [42]. The gene discussed is CD44; the disease is posterior cortical atrophy.